{"id":682584,"date":"2026-11-12T15:14:19","date_gmt":"2026-11-12T15:14:19","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/682584\/"},"modified":"2026-11-12T15:14:19","modified_gmt":"2026-11-12T15:14:19","slug":"how-glp-1-drugs-and-a-revamp-revived-ros-business","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/682584\/","title":{"rendered":"How GLP-1 Drugs and a Revamp Revived Ro\u2019s Business"},"content":{"rendered":"<p class=\"css-12m5bll evys1bk0\">For much of its life, the telehealth company Ro was known as a provider of sexual wellness treatments. Then it drastically reshaped its business and pivoted to offering weight-loss drugs like Wegovy and Zepbound as part of a health care revolution.<\/p>\n<p class=\"css-12m5bll evys1bk0\">Now, the nine-year-old privately held company is offering a closer look at the results of that transition.<\/p>\n<p class=\"css-12m5bll evys1bk0\">Ro <a class=\"css-povzk\" href=\"https:\/\/x.com\/ZReitano\/status\/2120502035455811893\" title=\"\" rel=\"noopener noreferrer nofollow\" target=\"_blank\">announced on Wednesday<\/a> that it had more than $3 billion in annualized revenue, up nearly tenfold since the company revamped its business starting in 2022.<\/p>\n<p class=\"css-12m5bll evys1bk0\">For Zachariah Reitano, a Ro founder and its chief executive, the results underscore both the efficacy of the company\u2019s overhaul and the huge draw of GLP-1 drugs, which <a class=\"css-povzk\" href=\"https:\/\/www.nytimes.com\/2026\/06\/08\/well\/glp1-drugs-weight-loss.html\" title=\"\" rel=\"nofollow noopener\" target=\"_blank\">can offer benefits<\/a> beyond weight loss.<\/p>\n<p class=\"css-12m5bll evys1bk0\">\u201cPeople will ask me, \u2018Are you just GLP-1s now?\u2019\u201d he said in an interview. \u201cAnd my response is, \u2018Just? Like, just working on the leading causes of death?\u2019\u201d<\/p>\n<p class=\"css-12m5bll evys1bk0\">The company\u2019s turnaround may also spur questions about whether Ro, which has not raised new money from investors in years, will eventually go public, following in the footsteps of its rival Hims &amp; Hers.<\/p>\n<p class=\"css-12m5bll evys1bk0\">Mr. Reitano also chalked up the company\u2019s success to what he called a badly needed reset. That came months after the company raised $500 million at a $5 billion valuation in spring 2021.<\/p>\n<p class=\"css-12m5bll evys1bk0\">At the time, its growth had plateaued at just 9 percent year-on-year-growth, in part because the company had tried to do too much and lost sight of its longer-term ambitions. \u201cWe were not going to die, but we were not growing,\u201d Mr. Reitano said. \u201cWe were just really a zombie company.\u201d<\/p>\n<p class=\"css-12m5bll evys1bk0\">What came next, Mr. Reitano said, was what he called a \u201cre-founding\u201d of Ro. That meant building what he called a \u201cstrong attract-repel culture\u201d to inspire the right kinds of employees, shutting more than 10 product lines and ditching longer-term product road maps.<\/p>\n<p class=\"css-12m5bll evys1bk0\">It also involved job cuts: By June 2022, the company had laid off about 20 percent of its work force, and another founder, Rob Schutz, stepped back from an executive role to an advisory one. (Mr. Reitano defended the need to reduce the head count, but added, \u201cI do think Silicon Valley glorifies layoffs in a way they shouldn\u2019t.\u201d)<\/p>\n<p class=\"css-12m5bll evys1bk0\">By 2023, Ro leaned into the rising popularity of GLP-1 drugs, introducing its Ro Body subscription service to help customers obtain treatments and navigate the insurance process.<\/p>\n<p class=\"css-12m5bll evys1bk0\">Ro has also began featuring celebrity endorsements of its weight-loss treatments, including a <a class=\"css-povzk\" href=\"https:\/\/www.nytimes.com\/2026\/02\/06\/arts\/television\/super-bowl-ads-ranked-2026.html\" title=\"\" rel=\"nofollow noopener\" target=\"_blank\">Super Bowl ad<\/a> this year featuring the tennis star Serena Williams talking about the drugs\u2019 health benefits. (Her husband, the technology executive Alexis Ohanian Sr., is a Ro investor and board member.)<\/p>\n<p class=\"css-12m5bll evys1bk0\">The spot drew attention to Ro \u2014 but perhaps not in a positive way, ranking <a class=\"css-povzk\" href=\"https:\/\/eu.usatoday.com\/story\/sports\/ad-meter\/2026\/02\/09\/super-bowl-60-ads-takeaways-ai-doesnt-fly\/88588381007\/\" title=\"\" rel=\"noopener noreferrer nofollow\" target=\"_blank\">near the bottom<\/a> of a survey by USA Today of Super Bowl ads. Mr. Reitano defended the ad: \u201cWhat she did took tremendous courage,\u201d he said, adding that it helped persuade more consumers to seek GLP-1 treatments.<\/p>\n<p class=\"css-12m5bll evys1bk0\">While the company became known in recent years for providing generic versions of GLP-1s during a <a class=\"css-povzk\" href=\"https:\/\/www.nytimes.com\/2023\/10\/05\/well\/live\/wegovy-shortage-ozempic-fda.html\" title=\"\" rel=\"nofollow noopener\" target=\"_blank\">shortage of drugs like Wegovy<\/a>, Mr. Reitano emphasized that the company had always worked directly with Novo Nordisk and Eli Lilly, the pharmaceutical giants behind Wegovy and Zepbound. He claims that Ro is now the largest provider of branded GLP-1 drugs in the United States.<\/p>\n<p class=\"css-12m5bll evys1bk0\">Selling branded drugs has taken a toll on telehealth companies\u2019 margins: Hims this week lowered its earnings guidance for the year as it emphasizes nongeneric offerings, while analysts at Barclays foresaw a nearly halving of adjusted profit margins at Hims.<\/p>\n<p class=\"css-12m5bll evys1bk0\">At the same time, both Novo Nordisk and Eli Lilly have been building up their own direct-to-consumer businesses as well as working with Ro.<\/p>\n<p class=\"css-12m5bll evys1bk0\">But Mr. Reitano defended Ro\u2019s business model, arguing that the company expected to maintain higher margins because of its subscriptions and its cost efficiency. He added that Ro had cut the cost of its membership plans, passing the savings onto customers.<\/p>\n<p class=\"css-12m5bll evys1bk0\">Artificial intelligence will play a big role, too, he said, including speeding up customer service queries and better personalizing a consumer\u2019s medical treatment. A.I., for instance, could recommend that a patient change an injection schedule based on workouts.<\/p>\n<p class=\"css-12m5bll evys1bk0\">Does the future of Ro also involve going public, as many analysts expect? Mr. Reitano demurred, saying that the company was able to fund its business from its operations and could be profitable if it chose to be.<\/p>\n<p class=\"css-12m5bll evys1bk0\">But, he added, \u201csometimes the best time to raise money is when you don\u2019t need it.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"For much of its life, the telehealth company Ro was known as a provider of sexual wellness treatments.&hellip;\n","protected":false},"author":2,"featured_media":682585,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[288611,187400,8177,105442,103,61,60,52040,371,4369,288610,288609,24297,200265],"class_list":["post-682584","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-company-reports","tag-drugs-pharmaceuticals","tag-e-commerce","tag-glp-1-ras-drug","tag-health","tag-ie","tag-ireland","tag-layoffs-and-job-reductions","tag-medication","tag-obesity","tag-reitano","tag-roman-health-ventures-inc","tag-telemedicine","tag-zachariah"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/682584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=682584"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/682584\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/682585"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=682584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=682584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=682584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}